Over 65 Companies Claim To Offer Drug Repurposing-related Services To The Global Pharmaceutical Industry; Interestingly, The Majority (>55%) Of Such Service Providers Firms Are Based In Europe, Claims Roots Analysis


over 65 companies claim to offer drug repurposing-related services to the global pharmaceutical industry; interestingly, the majority (>55%) of such service providers firms are based in Europe, claims Roots Analysis

Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged as a viable business strategy. The rising popularity of this approach can further be attributed to various benefits, such as reduced development timelines, decreased investments and relatively higher success rates (considering that the safety profiles of such candidates have already been established).


To order this 250+ page report, which features 100+ figures and 140+ tables, please visit this - https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html


The USD 1.2 billion (by 2030) financial opportunity within the drug repurposing service providers market has been analyzed across the following segments:

  • Type of Repurposing Approaches
  • Disease-centric approach
  • Target-centric approach
  • Drug-centric approach
  • Therapeutic Area
  • Same Therapeutic Area
  • Different Therapeutic Area
  • Type of Drug Molecule
  • Biologics 
  • Small Molecule
  • Key Geographical Region 
  • North America
  • Europe
  • Asia-Pacific


The Drug Repurposing Service Providers Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:

  • Auxillis Pharma
  • ChemBio Discovery Solutions
  • Excelra
  • GVK Bio
  • Iris Pharma
  • Lantern Pharma
  • PanXome
  • Pharmacelera
  • Physiogenex
  • Smart Pharma
  • Socium
  • SOM Biotech


Table of Contents


  1. Preface

    2. Executive Summary

  2. Introduction

  3. Market Landscape

  4. Role of Non-Profit / Academic Organizations


  1. Company Profiles

  2.  Partnerships

  3. Big Pharma Initiatives

  4. Case Study: Discontinued Drug Development Programs

  5. Cost Saving Analysis

  6. Market Forecast and Opportunity Analysis

  7. Covid-19 Impact on Drug Repurposing Service Providers Market

  8. Recent Advancements and Trends in Outsourcing of Drug Repurposing


  1. Interview Transcripts


  1. Appendix 1: List of Potential Drug-Indication Candidates for Drug Repurposing


  1. Appendix 2: Tabulated Data


  1. Appendix 3: List of Companies and Organizations


To purchase a copy, please visit https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html


Contact Details

Gaurav Chaudhary

+1 (415) 800 3415




Keywords: roots analysis,research,pharma,biotech,analysis,market research,industry reports,business report,global


Other related blogs

Why IV hydration therapy is the latest trend in cities

By : Replenish360

  If you feel lack of concentration and lethargic, understand that your body needs something e..

The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030, predicts Roots Analysis

By : Roots Analysis

Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), i..

AR / VR based Healthcare Digital Marketing Service Providers, 2020-2030

By : Roots Analysis

To order this 180+ page report, please visit this - https://www.rootsanalysis.com/reports/view_docum..